KatieB Posted April 17, 2010 Share Posted April 17, 2010 I'm pleased to let you know Genentech just issued a press release announcing that Tarceva has received FDA approval for use as a maintenance treatment for patients with locally advanced or metastatic non-small cell lung cancer (NSCLC). More details, including the exact approved indication, are included in the press release attached below. You can also view it at http://www.gene.com/gene/news/press-rel ... l&id=12727 Quote Link to comment Share on other sites More sharing options...
Jyoung20 Posted April 18, 2010 Share Posted April 18, 2010 great news!!!! Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.